Assisted Reproductive Technology Market Size By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), By Technology (In-Vitro Fertilization (IVF) {IVF with Intracytoplasmic Sperm Injection (ICSI), IVF without ICSI}, Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER)), By End-Use (Hospitals, Fertility Clinics) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Industry trends

Assisted Reproductive Technology Market size exceeded USD 26 billion in 2019 and is estimated to grow at 4.4% CAGR from 2020 to 2026.
 

Get more details on this report - Request Free Sample PDF
 

Assisted reproductive technology is used for the treatment of infertility. Several technologies included in treatment are ovulation induction, artificial insemination, in-vitro fertilization and gamete intrafallopian transfer among others. Newly introduced technologies are aimed at facilitating and intervening in the process of reproduction that includes contraception, antenatal testing, birth and conceptive technologies.
 

Some of the risk factors leading to infertility include aging, alcohol consumption, drugs and smoking along with changing lifestyle and habitats. Increasing prevalence of infertility owing to such factors will accelerate the market growth over forecast period. Moreover, introduction of new technologies will further offer growth opportunities.
 

Reduced risk of treatment complications owing to advancement in technologies will escalate the market demand

Adoption of unhealthy habits such as smoking, and alcohol consumption will significantly increase cases of infertility. Also, several other factors have impact on fertility including aging, weight, caffeine, exercise and diet. According to the Indian Journal of Community Medicine, about 60-80 million couples suffers from infertility affecting about 8-10% of couples every year. As per the World Health Organization, one in every four couples faces the issue in the developing countries, thereby leading to high the demand for assisted reproductive technology in future.
 

Advancement in assisted reproductive technology lead to higher success rates and minimized complications. Several government and public organizations are undertaking initiatives that will create awareness about new reproductive technologies. The European Society for Human Reproduction and Embryology established committee named Task Force on Infertility and Developing Countries that document and explores ART innovations across the globe. Thus, innovations in technologies couples with organizational initiatives will augment the market growth during analysis timeframe.
 

High success rates associated with fresh nondonor procedure will provide lucrative growth potential

Get more details on this report - Request Free Sample PDF
 

Increasing number of ART process due to growing infertility incidence will escalate the assisted reproductive technology market demand in the upcoming period. According to the Centers for Disease Control and Prevention’s report, approximately 1.7% of infants born in the U.S. are conceived by ART.
 

Fresh nondonor procedures market is expected to proceed at lucrative 6.8% CAGR in the forecast timeframe. High success rates associated with fresh nondonors will increase the segmental growth during forecast period.
 

Development of non-invasive embryo DNA screening will positively influence the IVF segment growth

Get more details on this report - Request Free Sample PDF
 

In-vitro fertilization is further classified into IVF with intracytoplasmic sperm injection and IVF without ICSI. In-vitro fertilization segment reported over 55% market share in 2019 and will witness momentous CAGR during projected period.
 

Advancement in treatment procedures will provide growth potential to in-vitro fertilization technique. IVF works with combination of medicines and surgical procedures. For instance, Australia’s fertility scientist have recently developed non-invasive embryo DNA screening that will further boosts IVF success rate, thereby positively impacting its adoption rate.
 

Rising number of ART cycles in fertility clinics will offer growth potential to the segment 

Fertility clinics will witness 4.1% CAGR during analysis timeframe. Developing infrastructure in fertility clinics owing to rising healthcare expenditure will increase number of procedures.
 

According to the Centers for Disease Control and Prevention’s 2016 Fertility Clinics report, over 260,000 ART cycles were performed at 463 clinics in the U.S. that has positively impacted the market growth. This, increasing inclination towards procedures in specialized facilities will boost the segmental size.
 

Escalating demand for ART in Spain will augment the regional market growth

Europe assisted reproductive technology market constituted over 35% market share in 2019 and is expected witness robust growth rate in the forthcoming years. According to the European Society of Human Reproduction and Embryology, in Europe about 157,000 were born using ART in 2015. Moreover, aging will further influence burden of infertility in the region.
 

Spain market will witness lucrative growth during the analysis period. Robust growth is attributed to increasing healthcare expenditure leading to the developing facilities in healthcare centers. Rising awareness through campaigns will further stimulate the demand for assisted reproductive technology in the country during forecast timeline.
 

Eminent industry players are focusing on new product launches will enhance market potential

Some of the prominent business players operating in the assisted reproductive technology industry share include The Cooper Companies Inc., Genea Limited, laboratoire CCD and Vitrolife AB among other players. These market players are adopting various inorganic growth strategies to gain market share and sustainable competitive advantage.
 

Some of the recent industry developments:

• In June 2019, Thermo Fisher Scientific collaborated with Predictive Laboratories, focused on research and development on genetic factors affecting women infertility that will allow advancements in firm’s products.
   
• In February 2019, Merck launched its fertility technologies named Geri, Gavi as well as Gems in India. This product launch will lead to business expansion of the firm in Asia-Pacific region.
   

The assisted reproductive technology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

By Procedure

• Fresh Donor
• Fresh Nondonor
• Frozen Donor
• Frozen Nondonor
• Embryo/Egg Banking

By Technology

• In-vitro Fertilization (IVF)
  • IVF with Intracytoplasmic Sperm Injection (ICSI)
  • IVF without ICSI
• Artificial Insemination-Intrauterine Insemination (AI-IUI)
• Frozen Embryo Replacement
• Others

By End-use

• Hospitals
• Fertility clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia